Streetbeat News

Products Services

HUMA

Humacyte announced that the FDA will require additional time to complete its review of the Biologics License Application (BLA) for ATEV in the treatment of vascular trauma.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:09 pm

FLYE

Fly-E Group has launched a new e-bike rental service, expanding its product offerings and potentially increasing its revenue streams.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:07 pm

LLY

NVO

Eli Lilly (NYSE:LLY) reported a 36% increase in Q2 revenue, driven by strong sales of Mounjaro and Zepbound. Analysts are optimistic about future drugs but cautious about supply and market dynamics. Price targets were raised by Goldman Sachs and Truist Securities, while Morningstar sees the stock as overvalued.

Portfolio Pulse from Vandana Singh

August 09, 2024 | 8:03 pm

AMZN

Amazon is partnering with TikTok and Pinterest to integrate shoppable ads, allowing users to buy products directly from Amazon without leaving the apps. This move is expected to add $1 billion in gross merchandise value and improve advertising ROI by 20%. BofA analyst Justin Post maintains a Buy rating on Amazon with a price target of $210, indicating a 26.7% upside.

Portfolio Pulse from Surbhi Jain

August 09, 2024 | 7:59 pm

FNCL

IYF

IYG

JPM

MS

VFH

XLF

JPMorgan Chase & Co. (NYSE:JPM) has introduced an AI assistant, LLM Suite, to over 60,000 employees to enhance productivity. The AI tool, developed with OpenAI's large language model, will assist in tasks like writing emails and reports. Competitors like Morgan Stanley (NYSE:MS) and Apple Inc. are also integrating AI tools. JPMorgan's shares rose 0.97% following the announcement. ETFs like IYG, XLF, IYF, VFH, and FNCL also saw slight gains.

Portfolio Pulse from Michael Juliano

August 09, 2024 | 7:47 pm

FXY

The USD/JPY exchange rate experienced significant volatility this week, driven by economic events and central bank actions. Analysts are debating the future of the dollar-yen carry trade, with some suggesting further yen strength and others seeing stabilization. The Invesco CurrencyShares Japanese Yen Trust (NYSE: FXY) remained largely unchanged despite the turbulence.

Portfolio Pulse from Piero Cingari

August 09, 2024 | 7:40 pm

GD

LMT

NOC

RTX

The U.S. has released $3.5 billion to Israel for the purchase of American weapons and military equipment. This move is expected to benefit U.S. defense contractors.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 7:33 pm

INTC

Intel has delayed its Innovation 2024 event due to financial challenges, causing a decline in its stock volume. This has raised public curiosity about the company's 18A process technology.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 7:26 pm

RNA

Avidity Biosciences shares are trading higher following the announcement of positive data for their AOC 1044 5 mg/kg treatment.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 7:23 pm

CGEM

MRK

Merck & Co Inc (NYSE:MRK) has agreed to acquire CN201, a bispecific antibody for B-cell-associated diseases, from Curon Biopharmaceutical for $1.3 billion. The deal is relevant to Cullinan Therapeutics Inc. (NASDAQ:CGEM) and its investigational drug CLN-978. Analysts see potential for CN201 in treating autoimmune diseases and highlight Cullinan's appealing valuation.

Portfolio Pulse from Vandana Singh

August 09, 2024 | 7:18 pm